28
Participants
Start Date
January 31, 2006
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2008
Octreotide-LAR
Octreotide-LAR 30 mg administered every 21 days until progression
University Federico II of Naples, Naples
University of Perugia, Faculty of Medicine, Department of Internal Medicine
OTHER
University of Genova
OTHER
University Hospital, Udine, Italy
OTHER
Federico II University
OTHER